BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17057734)

  • 1. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
    Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
    Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.
    Beltran AS; Sun X; Lizardi PM; Blancafort P
    Mol Cancer Ther; 2008 May; 7(5):1080-90. PubMed ID: 18483297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).
    Beltran AS; Blancafort P
    Epigenetics; 2011 Feb; 6(2):224-35. PubMed ID: 20948306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of breast tumor growth and metastasis by an engineered transcription factor.
    Beltran AS; Russo A; Lara H; Fan C; Lizardi PM; Blancafort P
    PLoS One; 2011; 6(9):e24595. PubMed ID: 21931769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors.
    Lara H; Wang Y; Beltran AS; Juárez-Moreno K; Yuan X; Kato S; Leisewitz AV; Cuello Fredes M; Licea AF; Connolly DC; Huang L; Blancafort P
    J Biol Chem; 2012 Aug; 287(35):29873-86. PubMed ID: 22782891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.
    Garcia-Bloj B; Moses C; Sgro A; Plani-Lam J; Arooj M; Duffy C; Thiruvengadam S; Sorolla A; Rashwan R; Mancera RL; Leisewitz A; Swift-Scanlan T; Corvalan AH; Blancafort P
    Oncotarget; 2016 Sep; 7(37):60535-60554. PubMed ID: 27528034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and regulation of tumor suppressor gene maspin in breast cancer.
    Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
    Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.
    Zhang M; Maass N; Magit D; Sager R
    Cell Growth Differ; 1997 Feb; 8(2):179-86. PubMed ID: 9040939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.
    Zhang M; Sheng S; Maass N; Sager R
    Mol Med; 1997 Jan; 3(1):49-59. PubMed ID: 9132279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.
    Maekawa T; Sano Y; Shinagawa T; Rahman Z; Sakuma T; Nomura S; Licht JD; Ishii S
    Oncogene; 2008 Feb; 27(8):1045-54. PubMed ID: 17700520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer.
    Maass N; Hojo T; Zhang M; Sager R; Jonat W; Nagasaki K
    Acta Oncol; 2000; 39(8):931-4. PubMed ID: 11206999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
    Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
    Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of maspin gene expression in human breast cancers.
    Domann FE; Rice JC; Hendrix MJ; Futscher BW
    Int J Cancer; 2000 Mar; 85(6):805-10. PubMed ID: 10709100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z; Shi HY; Nawaz Z; Zhang M
    Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maspin sensitizes breast carcinoma cells to induced apoptosis.
    Jiang N; Meng Y; Zhang S; Mensah-Osman E; Sheng S
    Oncogene; 2002 Jun; 21(26):4089-98. PubMed ID: 12037665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
    Chem Biol Interact; 2010 Feb; 183(3):455-61. PubMed ID: 19944674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-expression and epigenetic modification of maspin induced apoptosis in MCF-7 cells mediated by myocardin.
    Liao XH; Li YQ; Wang N; Zheng L; Xing WJ; Zhao DW; Yan TB; Wang Y; Liu LY; Sun XG; Hu P; Zhou H; Zhang TC
    Cell Signal; 2014 Jun; 26(6):1335-46. PubMed ID: 24607789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells.
    Neal CL; Henderson V; Smith BN; McKeithen D; Graham T; Vo BT; Odero-Marah VA
    BMC Cancer; 2012 Aug; 12():336. PubMed ID: 22857708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells.
    Khalkhali-Ellis Z; Hendrix MJ
    Am J Pathol; 2003 May; 162(5):1411-7. PubMed ID: 12707024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maspin. A tumor suppressing serpin.
    Sager R; Sheng S; Pemberton P; Hendrix MJ
    Adv Exp Med Biol; 1997; 425():77-88. PubMed ID: 9433491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.